Status:
COMPLETED
COVID-19 Vaccine Hesitancy Among Rheumatic Diseases Patients
Lead Sponsor:
National Institute of Medical Sciences and Nutrition, Salvador Zubiran
Conditions:
Covid19
Eligibility:
All Genders
18-99 years
Brief Summary
Rheumatological diseases (RD) are an important group of different clinical entities and specific diseases that affect a significant proportion of the world population. In Mexico, the RD have a relevan...
Detailed Description
The objectives are: 1. \- To measure the phenomenon of vaccine hesitancy in Mexican patients with RD from two Health Institutions in Mexico City. 2. \- Translate and adapt the "Oxford Covid-19 vaccin...
Eligibility Criteria
Inclusion
- Patients with a rheumatic disease diagnosis according to their primary rheumatologist who agree to participate
Exclusion
- Patients with a not confirmed rheumatic disease
Key Trial Info
Start Date :
February 1 2021
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
October 1 2021
Estimated Enrollment :
891 Patients enrolled
Trial Details
Trial ID
NCT04775563
Start Date
February 1 2021
End Date
October 1 2021
Last Update
April 6 2022
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Instituto Nacional de Ciencias Médicas y Nutrición Salvador Zubirán
Mexico City, Mexico, 14080